Tofimilast
Alternative Names: CP 325366Latest Information Update: 12 Aug 2008
At a glance
- Originator Pfizer
- Class 3-ring heterocyclic compounds; Antiasthmatics; Bronchodilators; Small molecules
- Mechanism of Action Type 4 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Chronic obstructive pulmonary disease
Most Recent Events
- 07 Jun 2002 unspecified for Asthma in USA (unspecified route)